COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 563: Articles 5621-5630  | Next

Trajectories of COVID-19: a longitudinal analysis of many nations and subnational regions
Burg, D., Ausubel, J. H.
10.1101/2023.01.19.23284768 — Posted: 2023-01-19
SARS-CoV-2 Omicron XBB.1.5 may be a cautionary variant by in silico study
Sugano, A., Kataguchi, H., Ohta, M., Someya, Y., Kimura, S., Maniwa, Y., Tabata, T., Takaoka, Y.
10.1101/2023.01.18.524660 — Posted: 2023-01-19
Effectiveness of Vaccination and Previous Infection Against Omicron Infection and Severe Outcomes in Children Under 12 Years of Age
Lin, D., Xu, Y., Gu, Y., Zeng, D., Wheeler, B., Young, H., Moore, Z., Sunny, S.
10.1101/2023.01.18.23284739 — Posted: 2023-01-19
The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: Safety and immunogenicity to Omicron BA.4/BA.5
Kanokudom, S., Chansaenroj, J., Suntronwong, N., Assawakosri, S., Yorsaeng, R., Nilyanimit, P., Aeemjinda, R., Khanarat, N., Vichaiwattana, P., Klinfueng, S., Thongmee, T., Srimuan, D., Thatsanatorn, T., Sudhinaraset, N., Wanlapakorn, N., Honsawek, S., Poovorawan, Y.
10.1101/2023.01.19.23284761 — Posted: 2023-01-19
Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort study
Chang, Y.-S., Huang, K., Lee, J. M., Vagts, C. L., Ascoli, C., Amin, M.-R., Ghassemi, M., Lora, C. M., Edafetanure-Ibeh, R., Huang, Y., Cherian, R. A., Sarup, N., Warpecha, S. R., Hwang, S., Goel, R., Turturice, B. A., Schott, C., Hernandez, M., Chen, Y., Jorgensen, J., Wang, W., Rasic, M., Novak, R. M., Perkins, D. L., Finn, P. W.
10.1101/2023.01.19.23284792 — Posted: 2023-01-19
Raman spectroscopy, used trans-cutaneously and non-invasively from a finger, to predict COVID-19: A feasibility, proof-of-concept study.
Chefitz, A. B., Birch, T., Yang, Y., Hussain, A.
10.1101/2023.01.19.23284747 — Posted: 2023-01-19
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection
Antar, A. A. R., Yu, T., Demko, Z. O., Hu, C., Tornheim, J. A., Blair, P. W., Thomas, D. L., Manabe, Y. C., OutSMART Study Group
10.1101/2023.01.18.23284742 — Posted: 2023-01-19
A computable phenotype for patients with SARS-CoV2 testing that occurred outside the hospital
Wang, L., Zipursky, A., Geva, A., McMurry, A., Mandl, K. D., Miller, T. A.
10.1101/2023.01.19.23284738 — Posted: 2023-01-19
Ensemble of deep learning language models to support the creation of living systematic reviews for the COVID-19 literature: a retrospective study
Knafou, J., Haas, Q., Borissov, N., Counotte, M. J., Low, N., Imeri, H., Ipekci, A. M., Buitrago-Garcia, D., Heron, L., Amini, P., Teodoro, D.
10.1101/2023.01.18.524571 — Posted: 2023-01-19
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
Moros, A., Prefaneta, A., Barreiro, A., Perozo, E., Fernandez, A., Canete, M., Gonzalez, L., Garriga, C., Pradenas, E., Marfil, S., Blanco, J., Cebollada-Rica, P., Sistere-Oro, M., Meyerhans, A., Prat Cabanas, T., March, R., Ferrer, L.
10.1101/2023.01.19.524684 — Posted: 2023-01-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).